Logo image of COHR

COHERENT CORP (COHR) Stock Fundamental Analysis

NYSE:COHR - New York Stock Exchange, Inc. - US19247G1076 - Common Stock - Currency: USD

93.3  -0.42 (-0.45%)

After market: 93.75 +0.45 (+0.48%)

Fundamental Rating

5

Taking everything into account, COHR scores 5 out of 10 in our fundamental rating. COHR was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. COHR has only an average score on both its financial health and profitability. COHR is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year COHR was profitable.
In the past year COHR had a positive cash flow from operations.
In multiple years COHR reported negative net income over the last 5 years.
In the past 5 years COHR always reported a positive cash flow from operatings.
COHR Yearly Net Income VS EBIT VS OCF VS FCFCOHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

COHR has a Return On Assets (-0.22%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -0.41%, COHR is in line with its industry, outperforming 51.20% of the companies in the same industry.
COHR has a Return On Invested Capital of 3.37%. This is comparable to the rest of the industry: COHR outperforms 57.60% of its industry peers.
COHR had an Average Return On Invested Capital over the past 3 years of 2.57%. This is significantly below the industry average of 9.16%.
The 3 year average ROIC (2.57%) for COHR is below the current ROIC(3.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.22%
ROE -0.41%
ROIC 3.37%
ROA(3y)-0.92%
ROA(5y)-0.01%
ROE(3y)-1.83%
ROE(5y)-0.48%
ROIC(3y)2.57%
ROIC(5y)2.95%
COHR Yearly ROA, ROE, ROICCOHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

Looking at the Operating Margin, with a value of 9.86%, COHR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Operating Margin of COHR has declined.
With a Gross Margin value of 34.48%, COHR perfoms like the industry average, outperforming 56.80% of the companies in the same industry.
In the last couple of years the Gross Margin of COHR has declined.
Industry RankSector Rank
OM 9.86%
PM (TTM) N/A
GM 34.48%
OM growth 3Y-33.11%
OM growth 5Y-22.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.56%
GM growth 5Y-4.17%
COHR Yearly Profit, Operating, Gross MarginsCOHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

COHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for COHR has been increased compared to 1 year ago.
Compared to 5 years ago, COHR has more shares outstanding
The debt/assets ratio for COHR has been reduced compared to a year ago.
COHR Yearly Shares OutstandingCOHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
COHR Yearly Total Debt VS Total AssetsCOHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

COHR has an Altman-Z score of 2.08. This is not the best score and indicates that COHR is in the grey zone with still only limited risk for bankruptcy at the moment.
COHR has a worse Altman-Z score (2.08) than 70.40% of its industry peers.
The Debt to FCF ratio of COHR is 14.56, which is on the high side as it means it would take COHR, 14.56 years of fcf income to pay off all of its debts.
COHR's Debt to FCF ratio of 14.56 is in line compared to the rest of the industry. COHR outperforms 53.60% of its industry peers.
COHR has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
COHR's Debt to Equity ratio of 0.48 is on the low side compared to the rest of the industry. COHR is outperformed by 71.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 14.56
Altman-Z 2.08
ROIC/WACC0.35
WACC9.54%
COHR Yearly LT Debt VS Equity VS FCFCOHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.47 indicates that COHR has no problem at all paying its short term obligations.
COHR's Current ratio of 2.47 is in line compared to the rest of the industry. COHR outperforms 52.00% of its industry peers.
A Quick Ratio of 1.54 indicates that COHR should not have too much problems paying its short term obligations.
COHR has a Quick ratio (1.54) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.54
COHR Yearly Current Assets VS Current LiabilitesCOHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. Growth

3.1 Past

COHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.86%, which is quite impressive.
COHR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.30% yearly.
COHR shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.67%.
The Revenue has been growing by 28.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)119.86%
EPS 3Y-23.51%
EPS 5Y-8.3%
EPS Q2Q%71.7%
Revenue 1Y (TTM)21.67%
Revenue growth 3Y14.87%
Revenue growth 5Y28.14%
Sales Q2Q%23.92%

3.2 Future

COHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.77% yearly.
The Revenue is expected to grow by 13.04% on average over the next years. This is quite good.
EPS Next Y115.77%
EPS Next 2Y66.12%
EPS Next 3Y48.77%
EPS Next 5YN/A
Revenue Next Year23.87%
Revenue Next 2Y16.6%
Revenue Next 3Y13.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
COHR Yearly Revenue VS EstimatesCOHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
COHR Yearly EPS VS EstimatesCOHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.07, COHR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of COHR indicates a somewhat cheap valuation: COHR is cheaper than 63.20% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, COHR is valued at the same level.
A Price/Forward Earnings ratio of 20.37 indicates a rather expensive valuation of COHR.
Based on the Price/Forward Earnings ratio, COHR is valued a bit cheaper than 67.20% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of COHR to the average of the S&P500 Index (21.76), we can say COHR is valued inline with the index average.
Industry RankSector Rank
PE 29.07
Fwd PE 20.37
COHR Price Earnings VS Forward Price EarningsCOHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

68.80% of the companies in the same industry are more expensive than COHR, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as COHR.
Industry RankSector Rank
P/FCF 56.6
EV/EBITDA 15.63
COHR Per share dataCOHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as COHR's earnings are expected to grow with 48.77% in the coming years.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y66.12%
EPS Next 3Y48.77%

0

5. Dividend

5.1 Amount

No dividends for COHR!.
Industry RankSector Rank
Dividend Yield N/A

COHERENT CORP

NYSE:COHR (7/11/2025, 8:04:00 PM)

After market: 93.75 +0.45 (+0.48%)

93.3

-0.42 (-0.45%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-13 2025-08-13/amc
Inst Owners92.97%
Inst Owner Change-0.01%
Ins Owners0.61%
Ins Owner Change-0.99%
Market Cap14.50B
Analysts81.48
Price Target99.32 (6.45%)
Short Float %4.76%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.23%
Min EPS beat(2)4.19%
Max EPS beat(2)34.28%
EPS beat(4)4
Avg EPS beat(4)14.27%
Min EPS beat(4)0.45%
Max EPS beat(4)34.28%
EPS beat(8)8
Avg EPS beat(8)19.29%
EPS beat(12)11
Avg EPS beat(12)12.37%
EPS beat(16)15
Avg EPS beat(16)11.12%
Revenue beat(2)2
Avg Revenue beat(2)2.12%
Min Revenue beat(2)1.9%
Max Revenue beat(2)2.33%
Revenue beat(4)4
Avg Revenue beat(4)1.44%
Min Revenue beat(4)0.53%
Max Revenue beat(4)2.33%
Revenue beat(8)6
Avg Revenue beat(8)0.91%
Revenue beat(12)7
Avg Revenue beat(12)-0.4%
Revenue beat(16)9
Avg Revenue beat(16)-0.61%
PT rev (1m)3.11%
PT rev (3m)-15.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.01%
EPS NY rev (1m)0.12%
EPS NY rev (3m)1.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.58%
Valuation
Industry RankSector Rank
PE 29.07
Fwd PE 20.37
P/S 2.59
P/FCF 56.6
P/OCF 21.79
P/B 1.86
P/tB 196.76
EV/EBITDA 15.63
EPS(TTM)3.21
EY3.44%
EPS(NY)4.58
Fwd EY4.91%
FCF(TTM)1.65
FCFY1.77%
OCF(TTM)4.28
OCFY4.59%
SpS35.99
BVpS50.27
TBVpS0.47
PEG (NY)0.25
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.22%
ROE -0.41%
ROCE 4.26%
ROIC 3.37%
ROICexc 3.61%
ROICexgc 10.1%
OM 9.86%
PM (TTM) N/A
GM 34.48%
FCFM 4.58%
ROA(3y)-0.92%
ROA(5y)-0.01%
ROE(3y)-1.83%
ROE(5y)-0.48%
ROIC(3y)2.57%
ROIC(5y)2.95%
ROICexc(3y)3.83%
ROICexc(5y)4.17%
ROICexgc(3y)8.28%
ROICexgc(5y)8.58%
ROCE(3y)3.26%
ROCE(5y)3.73%
ROICexcg growth 3Y-38.53%
ROICexcg growth 5Y-25%
ROICexc growth 3Y-46.21%
ROICexc growth 5Y-34.59%
OM growth 3Y-33.11%
OM growth 5Y-22.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.56%
GM growth 5Y-4.17%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 14.56
Debt/EBITDA 3.35
Cap/Depr 72.79%
Cap/Sales 7.32%
Interest Coverage 2
Cash Conversion 59.74%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 1.54
Altman-Z 2.08
F-Score6
WACC9.54%
ROIC/WACC0.35
Cap/Depr(3y)78.52%
Cap/Depr(5y)70.67%
Cap/Sales(3y)8.43%
Cap/Sales(5y)7.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.86%
EPS 3Y-23.51%
EPS 5Y-8.3%
EPS Q2Q%71.7%
EPS Next Y115.77%
EPS Next 2Y66.12%
EPS Next 3Y48.77%
EPS Next 5YN/A
Revenue 1Y (TTM)21.67%
Revenue growth 3Y14.87%
Revenue growth 5Y28.14%
Sales Q2Q%23.92%
Revenue Next Year23.87%
Revenue Next 2Y16.6%
Revenue Next 3Y13.04%
Revenue Next 5YN/A
EBIT growth 1Y226.98%
EBIT growth 3Y-23.16%
EBIT growth 5Y-0.2%
EBIT Next Year89.64%
EBIT Next 3Y34.79%
EBIT Next 5YN/A
FCF growth 1Y99.42%
FCF growth 3Y-22.55%
FCF growth 5Y36.88%
OCF growth 1Y12.86%
OCF growth 3Y-1.69%
OCF growth 5Y25.05%